177Lu-PSMA617
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 177Lu-PSMA617, covering 2022-06-13 to 2022-06-13. Get the full timeline:
Most recent: Clinical Trial Update: A Trial of 177Lu-PSMA617 Theranostic Versus Cabazitaxel in Progressive Metastatic Castration Resistant Prostate Cancer [Phase 2]